Testing effectiveness (Phase 2)Study completedNCT05887466
What this trial is testing
Study to Evaluate the Safety and Efficacy of ESC-derived Dopamine Progenitor Cell Therapy in PD Patients
Who this might be right for
Parkinson's Disease
S.Biomedics Co., Ltd. 12